HLF and breast carcinoma: In a breast cancer mouse model, orally administered hLF enhanced intestinal IFN-γ production, which was associated with expansion of NKT cells and CD8+ T cells, as well as increased systemic cytotoxicity of tumor-specific CD8+ T cells [245].